EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders

Min Kyu Park, Hyun Wook Yang, Seo Young Woo, Dong Yeon Kim, Dae-Soon Son iD, Bo Young Choi iD, Sang Won Suh

Cells · 2025

DOI: 10.3390/cells14020086 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Min Kyu Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea. Hauptthemen laut MEDLINE: Nervous System Diseases, Brain, Cyclic Nucleotide Phosphodiesterases, Type 4, Phosphodiesterase 5 Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hallym University Research Fund, National Research Foundation of Korea (NRF), Ministry of Education and National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase (PDE) enzymes regulate intracellular signaling pathways crucial for brain development and the pathophysiology of neurological disorders. Among the 11 PDE subtypes, PDE4 and PDE5 are particularly significant due to their regulation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) signaling, respectively, which are vital for learning, memory, and neuroprotection. This review synthesizes current evidence on the roles of PDE4 and PDE5 in neurological health and disease, focusing on their regulation of second messenger pathways and their implications for brain function. Elevated PDE4 activity impairs synaptic plasticity by reducing cAMP levels and protein kinase A (PKA) activity, contributing to cognitive decline, acute brain injuries, and neuropsychiatric conditions such as bipolar disorder and schizophrenia. Similarly, PDE5 dysregulation disrupts nitric oxide (NO) signaling and protein kinase G (PKG) pathways, which are involved in cerebrovascular homeostasis, recovery after ischemic events, and neurodegenerative processes in Alzheimer’s, Parkinson’s, and Huntington’s diseases. PDE4 and PDE5 are promising therapeutic targets for neurological disorders. Pharmacological modulation of these enzymes offers potential to enhance cognitive function and mitigate pathological mechanisms underlying brain injuries, neurodegenerative diseases, and psychiatric disorders. Further research into the regulation of PDE4 and PDE5 will advance therapeutic strategies for these conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nervous System DiseasesBrainCyclic Nucleotide Phosphodiesterases, Type 4Phosphodiesterase 5 InhibitorsCyclic Nucleotide Phosphodiesterases, Type 5Second Messenger SystemsPhosphodiesterase 4 InhibitorsHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

phosphodiesterase (PDE)phosphodiesterase 4 (PDE4)phosphodiesterase 5 (PDE5)protein kinase A (PKA)protein kinase G (PKG)

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 4Phosphodiesterase 5 InhibitorsCyclic Nucleotide Phosphodiesterases, Type 5Phosphodiesterase 4 Inhibitors

Autor:innen und Institutionen

  • Department of Physiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea.
  • Division of Data Science, Data Science Convergence Research Center, Hallym University, Chuncheon 24252, Republic of Korea.
  • Institute of Sport Science, Hallym University, Chuncheon 24252, Republic of Korea.
  • Department of Physical Education, Hallym University, Chuncheon 24252, Republic of Korea.

ORCID-Profile: Dae-Soon Son, Bo Young Choi

Förderung

  • Hallym University Research Fund
  • National Research Foundation of Korea (NRF)
  • Ministry of Education and National Research Foundation of Korea

Zitieren

APA

Park, M. K., Yang, H. W., Woo, S. Y., Kim, D. Y., Son, D. S., Choi, B. Y., & Suh, S. W. (2025). Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders. Cells. https://doi.org/10.3390/cells14020086

Vancouver

Park MK, Yang HW, Woo SY, Kim DY, Son DS, Choi BY, et al. Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders. Cells. 2025. doi:10.3390/cells14020086

BibTeX
@article{Park2025,
  author = {Park, Min Kyu and Yang, Hyun Wook and Woo, Seo Young and Kim, Dong Yeon and Son, Dae-Soon and Choi, Bo Young and Suh, Sang Won},
  title = {Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14020086}
}
Kostenlos starten →